Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
After a year in which Johnson & Johnson’s product quality control was deemed such a shambles that the U.S. government will oversee some plants, the board had praise for Chief Executive William Weldon and awarded him almost $29 million in overall compensation.
The once golden reputation of the diversified health care giant was tarnished by seemingly endless recalls of widely used consumer products as well as recalls of medical devices and products from other units in 2010. Get the full story »
Johnson & Johnson’s McNeil division, beset by an unstemmed tide of consumer product recalls, said Thursday that it had finalized a consent decree that would put three of its manufacturing facilities under supervision of U.S. health authorities.
McNeil said in a statement it had finalized the terms of a consent decree with the Food and Drug Administration for its facilities in Las Piedras, Puerto Rico, and Fort Washington and Lancaster, Pa. Get the full story »
U.S. health regulators knew that Johnson & Johnson’s McNeil unit was using a contractor to buy back potentially faulty batches of Motrin, though there was no formal agreement with the government, lawyers for the company told lawmakers.
Still, in a letter to the House Oversight and Government Reform Committee Wednesday, J&J’s lawyers said though the purchases of defective painkiller from retailers were legal, “moving forward the company would handle things differently.” Get the full story »
Johnson & Johnson is expanding a recall of over-the-counter drugs including Tylenol and Motrin IB because of a musty or moldy smell.
The McNeil Consumer Healthcare business says it is recalling 21 lots of over-the-counter drugs sold in the U.S., Puerto Rico, Fiji, Guatemala, Dominican Republic, Trinidad and Tobago and Jamaica. Get the full story »
